Latest SILK reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Silk Road Medical, Inc SILK

$ 20.41 6.14%

Silk Road Medical, Inc Balance Sheet 2011-2024 | SILK

Annual Balance Sheet Silk Road Medical, Inc

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	57.1 M	21.1 M	-64.4 M	-20.4 M	57.2 M	19.2 M	-5.74 M	-	-	-	-	-	-
Long Term Debt	75.6 M	74.6 M	44.8 M	48.5 M	44.9 M	44.2 M	27.6 M	-	-	-	-	-	-
Long Term Debt Current	1.7 M	1.84 M	1.29 M	850 K	769 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	48.6 M	45.3 M	137 M	-	-	-	-	-	-
Total Current Liabilities	30.3 M	24.5 M	26.1 M	19.6 M	16.9 M	-	-	-	-	-	-	-	-
Total Liabilities	114 M	106 M	77.4 M	71.8 M	65.5 M	54.1 M	142 M	-	-	-	-	-	-
Deferred Revenue	256 K	249 K	157 K	206 K	-	-	-	-	-	-	-	-	-
Retained Earnings	-399 M	-344 M	-289 M	-239 M	-192 M	-139 M	-102 M	-	-	-	-	-	-
Total Assets	265 M	270 M	157 M	179 M	137 M	40.9 M	43.1 M	-	-	-	-	-	-
Cash and Cash Equivalents	20.2 M	55.4 M	110 M	69.8 M	39.2 M	25.3 M	33.8 M	-	-	-	-	-	-
Book Value	151 M	164 M	79.2 M	108 M	71.9 M	-13.2 M	-98.6 M	-	-	-	-	-	-
Total Shareholders Equity	151 M	164 M	79.2 M	108 M	71.9 M	-135 M	-98.6 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Silk Road Medical, Inc

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	75.9 M	75.6 M	75.4 M	75.1 M	74.8 M	74.6 M	74.3 M	74 M	38.9 M	44.8 M	48.7 M	48.6 M	48.6 M	48.5 M	48.5 M	48.5 M	48.5 M	44.9 M	44.9 M	44.9 M	44.9 M	44.2 M	44.2 M	44.2 M	44.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	105 M	114 M	108 M	108 M	102 M	106 M	105 M	103 M	75.3 M	77.4 M	77.4 M	72.1 M	68.5 M	71.8 M	71.8 M	71.8 M	71.8 M	65.5 M	65.5 M	65.5 M	65.5 M	72.1 M	70.2 M	70.2 M	70.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	317 K	143 K	120 K	220 K	209 K	253 K	298 K	482 K	522 K	157 K	448 K	478 K	536 K	206 K	206 K	206 K	206 K	304 K	304 K	304 K	304 K	137 K	137 K	137 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-414 M	-399 M	-386 M	-374 M	-360 M	-344 M	-331 M	-321 M	-305 M	-289 M	-274 M	-260 M	-250 M	-239 M	-239 M	-239 M	-239 M	-192 M	-192 M	-192 M	-192 M	-139 M	-139 M	-139 M	-139 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	252 M	265 M	261 M	263 M	260 M	270 M	163 M	163 M	143 M	157 M	166 M	168 M	170 M	179 M	179 M	179 M	179 M	137 M	137 M	137 M	137 M	42.7 M	40.9 M	40.9 M	40.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	22.6 M	20.2 M	29.2 M	28.4 M	50.6 M	55.4 M	51.5 M	87.9 M	93.8 M	110 M	106 M	102 M	94.6 M	69.8 M	69.5 M	69.5 M	69.5 M	39.2 M	39.2 M	39.2 M	39.2 M	25 M	25 M	25 M	25 M	33.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	147 M	151 M	153 M	156 M	158 M	164 M	57.2 M	60 M	67.7 M	79.2 M	88.2 M	96.1 M	101 M	108 M	108 M	108 M	108 M	71.9 M	71.9 M	71.9 M	71.9 M	-29.3 M	-29.3 M	-29.3 M	-29.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	147 M	151 M	153 M	156 M	158 M	164 M	57.2 M	60 M	67.7 M	79.2 M	88.2 M	96.1 M	101 M	108 M	108 M	108 M	108 M	71.9 M	71.9 M	71.9 M	71.9 M	-135 M	-135 M	-135 M	-135 M	-98.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency